Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TEAD (TEA domain transcription factor) family proteins are a group of highly conserved transcription factors defined by their TEA/ATTS DNA-binding domain[1][5]. They serve as critical downstream effectors of the Hippo pathway, binding cofactors such as YAP, TAZ, and others to regulate gene transcription involved in growth, proliferation, and survival[2][6]. TEAD proteins play essential roles in organ development and homeostasis, and their dysregulation (most often via aberrant Hippo pathway signaling) has been implicated in tumorigenesis, stemness, and chemoresistance in various cancers[1][2][5]. Pharmacological inhibition of TEAD, especially disrupting their interaction with YAP/TAZ, is being explored as a novel anti-cancer approach[3][2][5].
Disruption of TEAD–YAP/TAZ interaction (allosteric and covalent inhibition)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TEA domain transcription factor family (TEAD).